2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

T.A. McDonagh*, M. Metra*, M. Adamo, R.S. Gardner, A. Baumbach, M. Bohm, H. Burri, J. Butler, J. Celutkiene, O. Chioncel, J.G.F. Cleland, A.J.S. Coats, M.G. Crespo-Leiro, D. Farmakis, M. Gilard, S. Heymans, A.W. Hoes, T. Jaarsma, E.A. Jankowska, M. LainscakC.S.P. Lam, A.R. Lyon, J.J.V. McMurray, A. Mebazaa, R. Mindham, C. Muneretto, M.F. Piepoli, S. Price, G.M.C. Rosano, F. Ruschitzka, A.K. Skibelund, ESC Scientific Document Group

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

39 Citations (Web of Science)
Original languageEnglish
Pages (from-to)3599-3726
Number of pages128
JournalEuropean Heart Journal
Volume42
Issue number36
DOIs
Publication statusPublished - 21 Sep 2021

Keywords

  • Guidelines
  • heart failure
  • natriuretic peptides
  • ejection fraction
  • diagnosis
  • pharmacotherapy
  • neuro-hormonal antagonists
  • cardiac resynchronization therapy
  • mechanical circulatory support
  • transplantation
  • arrhythmias
  • comorbidities
  • hospitalization
  • multidisciplinary management
  • advanced heart failure
  • acute heart failure
  • CARDIAC-RESYNCHRONIZATION THERAPY
  • PRESERVED EJECTION FRACTION
  • VENTRICULAR ASSIST DEVICE
  • QUALITY-OF-LIFE
  • IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
  • AORTIC-VALVE-REPLACEMENT
  • CORONARY-ARTERY-DISEASE
  • ACUTE MYOCARDIAL-INFARCTION
  • BRAIN NATRIURETIC PEPTIDE
  • WORSENING RENAL-FUNCTION

Cite this